Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Protective Effects of Oral L-Arginine Supplement in Patients With CKD After Intravenous Contrast Media Injection

NCT02455960 is registered in ClinicalTrials.gov with Phramongkutklao College of Medicine and Hospital as lead sponsor.

NCT NCT02455960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02455960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Protective Effects of Oral L-Arginine Supplement in Patients With CKD After Intravenous Contrast Media Injection
Lead sponsor
Phramongkutklao College of Medicine and Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2014
Completion date
May 31, 2016
Enrollment
112 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast induced aki